ChenGuang Biotech Group Co., Ltd. (SHE:300138)
China · Delayed Price · Currency is CNY 11.18
-0.11 (-0.97%)
May 7, 2026, 10:55 AM CST
ChenGuang Biotech Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 356.11 | 368.87 | 94.05 | 479.72 | 434.03 | 351.51 |
Depreciation & Amortization | 183.4 | 183.4 | 166.95 | 152.83 | 144.85 | 130.74 |
Other Amortization | 1.05 | 1.05 | 0.2 | 0.2 | 0.9 | 0.2 |
Loss (Gain) From Sale of Assets | -1.46 | -1.46 | -4.89 | 0.63 | -1.08 | -0.1 |
Asset Writedown & Restructuring Costs | 6.94 | 6.94 | 0.46 | 1.1 | 1.32 | 10.91 |
Loss (Gain) From Sale of Investments | -55.63 | -55.63 | -12.68 | -74.02 | -33.45 | -30.93 |
Provision & Write-off of Bad Debts | 4.89 | 4.89 | 0.11 | 0.87 | 0.77 | -1.93 |
Other Operating Activities | -112.93 | 127.9 | 197.19 | 80.74 | 100.25 | 74.9 |
Change in Accounts Receivable | -8.24 | -8.24 | 62.07 | 135.24 | -274.17 | -119.09 |
Change in Inventory | -391.83 | -391.83 | -670.57 | -1,145 | 187.13 | -435.93 |
Change in Accounts Payable | -31.41 | -31.41 | -41.67 | -211.8 | 176.31 | 90 |
Operating Cash Flow | -40.68 | 212.91 | -222.81 | -588.47 | 734.81 | 63.9 |
Operating Cash Flow Growth | - | - | - | - | 1049.93% | -87.93% |
Capital Expenditures | -136.19 | -135.26 | -149.54 | -189.2 | -176.03 | -280.82 |
Sale of Property, Plant & Equipment | 0.1 | 4.48 | 0.02 | 0.28 | 0.42 | 3.58 |
Divestitures | -0.28 | -0.28 | - | - | - | - |
Investment in Securities | 301.38 | 53.04 | -315.58 | -336.91 | -540.91 | - |
Other Investing Activities | 61.41 | 69.52 | 24.15 | 77.56 | 20.12 | 12.47 |
Investing Cash Flow | 226.43 | -8.5 | -440.95 | -448.27 | -696.4 | -264.76 |
Long-Term Debt Issued | - | 5,976 | 5,783 | 4,678 | 3,511 | 2,081 |
Total Debt Issued | 6,586 | 5,976 | 5,783 | 4,678 | 3,511 | 2,081 |
Long-Term Debt Repaid | - | -5,767 | -5,088 | -3,381 | -3,132 | -1,278 |
Total Debt Repaid | -6,077 | -5,767 | -5,088 | -3,381 | -3,132 | -1,278 |
Net Debt Issued (Repaid) | 508.8 | 208.69 | 695.8 | 1,297 | 378.58 | 803.12 |
Repurchase of Common Stock | - | - | -396.53 | -95.84 | - | - |
Common Dividends Paid | -167.45 | -159.85 | -174.05 | -181.41 | -143.98 | -109.77 |
Other Financing Activities | -39.59 | 20.62 | -21.41 | 276.95 | -195.55 | -152.39 |
Financing Cash Flow | 301.77 | 69.45 | 103.8 | 1,297 | 39.05 | 540.96 |
Foreign Exchange Rate Adjustments | -0.07 | -3.62 | -10.49 | -6.05 | -4.94 | -4.36 |
Net Cash Flow | 487.45 | 270.24 | -570.46 | 254.03 | 72.51 | 335.75 |
Free Cash Flow | -176.87 | 77.65 | -372.35 | -777.67 | 558.78 | -216.92 |
Free Cash Flow Margin | -2.73% | 1.18% | -5.32% | -11.32% | 8.88% | -4.45% |
Free Cash Flow Per Share | -0.37 | 0.16 | -0.72 | -1.46 | 1.05 | -0.41 |
Cash Income Tax Paid | 61.78 | -8.37 | 7.26 | 9.45 | -46.55 | -31.36 |
Levered Free Cash Flow | -558.79 | -717.46 | 39.79 | -997.32 | -131.42 | -423.74 |
Unlevered Free Cash Flow | -502.02 | -660.69 | 111.3 | -945.13 | -89.42 | -390.52 |
Change in Working Capital | -423.06 | -423.06 | -664.21 | -1,231 | 87.21 | -471.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.